Lonza Group (LZAGY) Stock Forecast & Price Target

$69.74 -2.14 (-2.98%)

As of 06/13/2025 03:59 PM Eastern

Lonza Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Buy

Based on 3 Analyst Ratings

Sell
0

Hold
0

Buy
3

Based on 3 Wall Street analysts who have issued ratings for Lonza Group in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 3 analysts, 3 have given a strong buy rating for LZAGY.

Consensus Price Target

N/A

Get the Latest News and Ratings for LZAGY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lonza Group and its competitors.

LZAGY Analyst Ratings Over Time

Type	Current Forecast 6/14/24 to 6/14/25	1 Month Ago 5/15/24 to 5/15/25	3 Months Ago 3/16/24 to 3/16/25	1 Year Ago 6/15/23 to 6/14/24
Strong Buy	3 Strong Buy rating(s)	3 Strong Buy rating(s)	3 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Strong Buy	Strong Buy	Strong Buy	Buy

LZAGY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

LZAGY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Lonza Group Stock vs. The Competition

Type	Lonza Group	Medical Companies	S&P 500
Consensus Rating Score	4.00	2.81	2.54
Consensus Rating	Strong Buy	Moderate Buy	Moderate Buy
Predicted Upside	N/A	6,245.73% Upside	14.80% Upside
News Sentiment Rating	Neutral News See Recent LZAGY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating
11/27/2024	Redburn Atlantic 5 of 5 stars	J. Clark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
10/9/2024	The Goldman Sachs Group 3 of 5 stars	J. Quigley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/23/2024	Berenberg Bank 2 of 5 stars	S. Bray Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
2/2/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
10/9/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight
7/14/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:50 AM ET.

Should I Buy Lonza Group Stock? LZAGY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, June 12, 2025. Please send any questions or comments about these Lonza Group pros and cons to contact@marketbeat.com.

Lonza Group
Bull Case

Here are some ways that investors could benefit from investing in Lonza Group AG:

The current stock price is around $71.88, reflecting a positive trend in recent trading sessions.
Lonza Group AG has recently increased its dividend to $0.1054, which indicates a commitment to returning value to shareholders and suggests financial stability.
Short interest in the company has decreased significantly, indicating growing investor confidence and potentially less volatility in the stock price.
The company has a solid current ratio of 1.52, which means it has more current assets than current liabilities, suggesting good short-term financial health.
Lonza Group AG operates in the pharmaceutical and biotech sectors, which are expected to grow, providing a favorable environment for long-term investment.

Lonza Group
Bear Case

Investors should be bearish about investing in Lonza Group AG for these reasons:

Despite the recent increase in stock price, the company has experienced fluctuations, which may indicate underlying market volatility.
The debt-to-equity ratio stands at 0.45, which, while not excessively high, suggests that the company does carry some debt that could impact financial flexibility.
Short interest saw a significant increase of 200% in May, which could indicate that some investors are betting against the stock, reflecting potential concerns about future performance.
The trading volume has been lower than average recently, which may suggest reduced investor interest or liquidity issues.
Market conditions in the pharmaceutical and biotech sectors can be unpredictable, influenced by regulatory changes and competition, which could pose risks to investment returns.

LZAGY Forecast - Frequently Asked Questions

: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There are currently 3 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "strong buy" LZAGY shares.
: According to analysts, Lonza Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Analysts like Lonza Group more than other "medical" companies. The consensus rating for Lonza Group is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how LZAGY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (OTCMKTS:LZAGY) was last updated on 6/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lonza Group (LZAGY) Stock Forecast & Price Target